Výsledky vyhledávání - "Stefan A. Nass"

Akademický článek

A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6–35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The GambiaResearch in context

Autor: Nuredin I. Mohammed, James Wason, Thomas Mendy, Stefan A. Nass, Ogochukwu Ofordile, Famalang Camara, Bakary Baldeh, Chilel Sanyang, Amadou T. Jallow, Ilias Hossain, Nuno Faria, Jonathan J. Powell, Andrew M. Prentice, Dora I.A. Pereira

Publikováno v: EClinicalMedicine, Vol 56, Iss , Pp 101853- (2023)

Summary: Background: Iron deficiency anaemia (IDA) is the leading cause of years lost to disability in most sub-Saharan African countries and is especially common in young children. The IHAT-GUT trial assessed the efficacy and safety of a novel nano

Externí odkaz: https://doaj.org/article/56b4665a85594747888ec90dfb701dcc

Zobrazit plný text záznamu

Akademický článek

Hemoglobin point-of-care testing in rural Gambia: Comparing accuracy of HemoCue and Aptus with an automated hematology analyzer

Autor: Stefan A. Nass, Ilias Hossain, Chilel Sanyang, Bakary Baldeh, Dora I. A. Pereira, Simeon-Pierre Choukem

Publikováno v: PLoS ONE, Vol 15, Iss 10 (2020)

Background Anemia is one of the most impactful nutrient deficiencies in the world and disproportionately affects children in low-resource settings. Point-of-care devices (PoCDs) measuring blood hemoglobin (Hb) are widely used in such settings to scre

Externí odkaz: https://doaj.org/article/29f76dabdcdf45e7ba635842a0ac1d3c

Zobrazit plný text záznamu

Plný text ve formátu HTML

A novel nano-iron supplement versus standard treatment for iron deficiency anaemia in children 6-35 months (IHAT-GUT trial): a double-blind, randomised, placebo-controlled non-inferiority phase II trial in The Gambia

BACKGROUND: Iron deficiency anaemia (IDA) is the leading cause of years lost to disability in most sub-Saharan African countries and is especially common in young children. The IHAT-GUT trial assessed the efficacy and safety of a novel nano iron supp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b920dd3861ecb2d9d661d1e01537d5ca

Zobrazit plný text záznamu

A Novel Nano-Iron Supplement Versus Standard Treatment for Iron Deficiency Anaemia in Children 6-35 Months (IHAT-GUT Trial): A Double-Blind, Randomised, Placebo-Controlled Non-Inferiority Trial in the Gambia

Autor: Dora I. A. Pereira, Nuredin Mohammed, Stefan Akio Nass, Thomas Mendy, Ogochukwu Ofordile, Nuno Faria, James Wason, Ilias Hossain, Amadou T. Jallow, Andrew M. Prentice, Chilel Sanyang, Famalang Camara, Jonathan J. Powell, Bakary Baldeh

Publikováno v: SSRN Electronic Journal.

Background: Iron deficiency anaemia (IDA) is the leading cause of years lost to disability in most sub-Saharan African countries and is especially common in young children. The IHAT-GUT trial assessed the efficacy and safety of a novel nano iron supp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6fc6bdff1abf43d6bf02da77a42dd590
https://doi.org/10.2139/ssrn.3899113

Zobrazit plný text záznamu

Hemoglobin point-of-care testing in rural Gambia: Comparing accuracy of HemoCue and Aptus with an automated hematology analyzer

Autor: Ilias Hossain, Bakary Baldeh, Stefan Akio Nass, Dora I. A. Pereira, Chilel Sanyang

Publikováno v: PLoS ONE, Vol 15, Iss 10, p e0239931 (2020)

BackgroundAnemia is one of the most impactful nutrient deficiencies in the world and disproportionately affects children in low-resource settings. Point-of-care devices (PoCDs) measuring blood hemoglobin (Hb) are widely used in such settings to scree

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::27b5e9eece7a8aba93699f233aadb2c8
https://www.repository.cam.ac.uk/handle/1810/310988

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání